For Immediate Release
FDA Voluntary Guidance on Antibiotics Tragically Flawed
Statement of CSPI Food Safety Director Caroline Smith DeWaal
WASHINGTON - The Food and Drug Administration's new policies intended to reduce the overuse of important antibiotics in animal production are tragically flawed. They rely too heavily on the drug industry and animal producers to act voluntarily in the best interest of consumers. Protecting public health is an authority and a responsibility that rests squarely with the FDA.
The announcement at least indicates that the agency recognizes a "public health imperative" to tackle this problem. Decades of misuse have led to some common pathogens, like Salmonella, becoming more virulent and less treatable. The FDA knows it can no longer afford to ignore antibiotic resistance. In March, the agency took a step in the right direction by banning certain extra-label uses of cephalosporin in certain food-producing animals. And last month, a federal court held that the agency must proceed with withdrawal actions on antibiotics. Many of these issues are addressed in the Preservation of Antibiotics in Medical Treatment Act, which the Administration should support. PAMTA would require the FDA to conduct regular reevaluation of drugs used in animal production.
This is the world we live in. This is the world we cover.
Because of people like you, another world is possible. There are many battles to be won, but we will battle them together—all of us. Common Dreams is not your normal news site. We don't survive on clicks. We don't want advertising dollars. We want the world to be a better place. But we can't do it alone. It doesn't work that way. We need you. If you can help today—because every gift of every size matters—please do. Without Your Support We Simply Don't Exist.